A detailed history of South State Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, South State Corp holds 55 shares of EXAS stock, worth $3,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 191 71.2%
Holding current value
$3,686
Previous $10,000 70.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$40.91 - $56.0 $5,563 - $7,616
-136 Reduced 71.2%
55 $3,000
Q2 2025

Aug 06, 2025

SELL
$40.31 - $58.08 $2,539 - $3,659
-63 Reduced 24.8%
191 $10,000
Q1 2025

May 12, 2025

BUY
$43.04 - $58.51 $10,932 - $14,861
254 New
254 $10,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.